Cargando…
Inhibiting Human and Leishmania Arginases Using Cannabis sativa as a Potential Therapy for Cutaneous Leishmaniasis: A Molecular Docking Study
Cutaneous leishmaniasis (CL), a vector-borne parasitic disease caused by the Leishmania protozoan, is a serious public health problem in Morocco. The treatment of this disease is still based on pentavalent antimonials as the primary therapy, but these have associated side effects. Thus, the developm...
Autores principales: | Assouab, Aicha, El Filaly, Hajar, Akarid, Khadija |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9783378/ https://www.ncbi.nlm.nih.gov/pubmed/36548655 http://dx.doi.org/10.3390/tropicalmed7120400 |
Ejemplares similares
-
Molecular identification of Leishmania infection in the most relevant sand fly species and in patient skin samples from a cutaneous leishmaniasis focus, in Morocco
por: Mhaidi, Idris, et al.
Publicado: (2018) -
Environmental, Climatic, and Parasite Molecular Factors Impacting the Incidence of Cutaneous Leishmaniasis Due to Leishmania tropica in Three Moroccan Foci
por: Daoui, Othmane, et al.
Publicado: (2022) -
Dissecting Platelet’s Role in Viral Infection: A Double-Edged Effector of the Immune System
por: El Filaly, Hajar, et al.
Publicado: (2023) -
Possible introduction of Leishmania tropica to urban areas determined by epidemiological and clinical profiles of patients with cutaneous leishmaniasis in Casablanca (Morocco)
por: Baghad, Bouchra, et al.
Publicado: (2020) -
Local Increase of Arginase Activity in Lesions of Patients with Cutaneous Leishmaniasis in Ethiopia
por: Abebe, Tamrat, et al.
Publicado: (2012)